Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Cambrex Corp (CBM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart
Realtime quote and/or trade prices are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,607,859
  • Shares Outstanding, K 32,780
  • Annual Sales, $ 490,640 K
  • Annual Income, $ 81,680 K
  • 36-Month Beta 2.26
  • Price/Sales 3.28
  • Price/Cash Flow 13.81
  • Price/Book 3.22

Price Performance

See More
Period Period Low Period High Performance
1-Month
42.55 +14.81%
on 11/06/17
50.90 -4.03%
on 10/25/17
-2.10 (-4.12%)
since 10/24/17
3-Month
42.55 +14.81%
on 11/06/17
57.30 -14.75%
on 10/05/17
-3.10 (-5.97%)
since 08/24/17
52-Week
42.55 +14.81%
on 11/06/17
62.95 -22.40%
on 05/04/17
-0.95 (-1.91%)
since 11/23/16

Most Recent Stories

More News
Corporate News Blog - Puma Biotechnology's 5-Year Analysis of Phase-III ExteNET Study Gets Published in â??The Lancet Oncology'

Research Desk Line-up: Cambrex Post Earnings Coverage

PBYI : 101.65 (-0.73%)
CBM : 48.85 (-0.41%)
Cambrex Invests in New Small Scale Capacity at Its Charles City, Iowa Facility

Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that it has completed an expansion of cGMP small...

CBM : 48.85 (-0.41%)
Cambrex Reports Third Quarter 2017 Financial Results

- Net Revenue increased 13% and EBITDA increased 29% vs. prior year quarter -

CBM : 48.85 (-0.41%)
Cambrex Corporation to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / November 7, 2017 / Cambrex Corporation (NYSE: CBM) will be discussing their earnings results in their Q3 Earnings Call to be held on November 7, 2017 at 8:30 AM Eastern Time....

CBM : 48.85 (-0.41%)
Gregory B. Brown M.D. Appointed to the Board of Directors of Cambrex Corporation

Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that Gregory B. Brown, M.D. was appointed to the...

CLBS : 3.58 (+1.99%)
CBM : 48.85 (-0.41%)
Cambrex to Announce Third Quarter 2017 Financial Results on November 7, 2017

Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that third quarter 2017 financial results will be...

CBM : 48.85 (-0.41%)
Cambrex Becomes Oversold (CBM)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

CBM : 48.85 (-0.41%)
Cambrex Adds Large Scale Manufacturing Capacity at Its Charles City, Iowa Facility

Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced the completion of an expansion to its large scale...

CBM : 48.85 (-0.41%)
Cambrex Invests in Generic API Development and Manufacturing Capabilities at Its Milan Site

Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that it has made a number of investments, in both...

CBM : 48.85 (-0.41%)
Tecan initiates succession process for the Board of Directors

Tecan Group AG / Tecan initiates succession process for the Board of Directors . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement....

NVIV : 1.30 (+1.96%)
TCHBF : 191.0000 (unch)
OSIR : 5.7200 (-2.22%)
PKI : 73.36 (+0.44%)
CBM : 48.85 (-0.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Cambrex Corporation manufactures and markets a broad line of specialty chemicals and commodity chemical intermediates and also manufactures chemicals to customer specifications. There are five product categories: pharmaceutical bulk actives; pharmaceutical intermediates; organic intermediates; performance...

See More

Key Turning Points

2nd Resistance Point 50.28
1st Resistance Point 49.57
Last Price 48.85
1st Support Level 48.32
2nd Support Level 47.78

See More

52-Week High 62.95
Fibonacci 61.8% 55.16
Fibonacci 50% 52.75
Fibonacci 38.2% 50.34
Last Price 48.85
52-Week Low 42.55

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart